IndustryPayments

SCOTT GREGORY SATKO

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology WINSTON SALEM, NC NPI 1962487397

Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NC NOVARTIS PHARMACEUTICALS CORPORATION All categories

General Payments — all program years on this page

$8,490.74

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 426
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $932.34 across 50 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $932.3450

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $113.166
Acerta Pharma LLC $106.906
Retrophin, Inc. $78.924
Boehringer Ingelheim Pharmaceuticals, Inc. $70.244
Amgen Inc. $61.443
ANI Pharmaceuticals, Inc. $59.244
Aurinia Pharma U.S., Inc. $55.622
Relypsa, Inc. $50.982
CALLIDITAS THERAPEUTICS US INC. $47.883
Novo Nordisk AS $35.162
GlaxoSmithKline, LLC. $33.712
Ardelyx, Inc. $33.652
Lilly USA, LLC $31.172
SHIELD THERAPEUTICS INC $30.612
Daiichi Sankyo Inc. $26.761
Outset Medical Inc $23.671
BAXTER HEALTHCARE $22.091
AKEBIA THERAPEUTICS INC $19.011
Fresenius USA Marketing, Inc. $18.231
Alexion Pharmaceuticals, Inc. $13.901

By program year

Program yearAmountRecords
2018 $1,409.8275
2019 $1,336.3076
2020 $838.8341
2021 $364.6812
2022 $1,508.7272
2023 $2,100.05100
2024 $932.3450

Records — PY2024 (50)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087256805 Novartis Pharmaceuticals Corporation $17.94 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087256807 Novartis Pharmaceuticals Corporation $17.48 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087256809 Novartis Pharmaceuticals Corporation $16.89 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087256811 Novartis Pharmaceuticals Corporation $18.30 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087256815 Novartis Pharmaceuticals Corporation $14.50 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087256817 Novartis Pharmaceuticals Corporation $28.05 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089478685 Daiichi Sankyo Inc. $26.76 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091147006 ANI Pharmaceuticals, Inc. $14.78 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091154504 ANI Pharmaceuticals, Inc. $14.96 12/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091155602 ANI Pharmaceuticals, Inc. $14.55 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091164520 ANI Pharmaceuticals, Inc. $14.95 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096699352 Novo Nordisk Inc $17.63 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097604669 Novo Nordisk Inc $17.53 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110532033 AstraZeneca Pharmaceuticals LP $17.22 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110539451 AstraZeneca Pharmaceuticals LP $15.75 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110541807 AstraZeneca Pharmaceuticals LP $26.17 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110546447 AstraZeneca Pharmaceuticals LP $16.53 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110546711 Alexion Pharmaceuticals, Inc. $13.90 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110552206 AstraZeneca Pharmaceuticals LP $15.44 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110554126 AstraZeneca Pharmaceuticals LP $15.79 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116089438 Amgen Inc. $25.97 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116208582 GlaxoSmithKline, LLC. $16.88 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116683499 GlaxoSmithKline, LLC. $16.83 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117675881 Amgen Inc. $18.36 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117675883 Amgen Inc. $17.11 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252554 Boehringer Ingelheim Pharmaceuticals, Inc. $19.45 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252556 Boehringer Ingelheim Pharmaceuticals, Inc. $15.77 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252558 Boehringer Ingelheim Pharmaceuticals, Inc. $17.04 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252560 Boehringer Ingelheim Pharmaceuticals, Inc. $17.98 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120646954 Baxter Healthcare $22.09 01/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124054989 Vifor Pharma, Inc. $25.88 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124058141 Vifor Pharma, Inc. $25.10 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135399199 Lilly USA, LLC $17.53 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135417997 Lilly USA, LLC $13.64 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138611688 Outset Medical Inc $23.67 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141522293 CALLIDITAS THERAPEUTICS US INC. $15.96 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141525146 CALLIDITAS THERAPEUTICS US INC. $18.54 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141529427 CALLIDITAS THERAPEUTICS US INC. $13.38 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145830839 AKEBIA THERAPEUTICS INC $19.01 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146705979 Ardelyx, Inc. $17.76 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146705981 Ardelyx, Inc. $15.89 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149945011 Travere Therapeutics, Inc. $18.63 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149945015 Travere Therapeutics, Inc. $19.50 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149945019 Travere Therapeutics, Inc. $20.22 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149945023 Travere Therapeutics, Inc. $20.57 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150137917 SHIELD THERAPEUTICS INC $16.27 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150145712 SHIELD THERAPEUTICS INC $14.34 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150691542 Aurinia Pharma U.S., Inc. $40.09 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150691544 Aurinia Pharma U.S., Inc. $15.53 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154198950 Fresenius USA Marketing, Inc. $18.23 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.